Therini Bio, Inc. develops fibrin-targeting immunotherapies to treat neurodegenerative diseases such as Alzheimer's Disease and Diabetic Macular Edema.

HAYA Therapeutics develops precision RNA-guided therapeutics targeting long non-coding RNA for treating aggressive solid tumors and other diseases.

Refoxy Pharmaceuticals is a biotech company developing small molecule activators of the FOXO3 transcription factor to treat age-related diseases, with an initial focus on idiopathic pulmonary fibrosis.

Nosh.bio is a Berlin-based foodtech startup that develops fermented fungi-based meat analogs, such as their Koji Chunks, to promote mass market adoption of alternative proteins.